Original BioMedicals Co., Ltd.

TPEX:6483 Stock Report

Market Cap: NT$755.6m

Original BioMedicals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Cliff Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.2yrs
CEO ownershipn/a
Management average tenure8.2yrs
Board average tenure8.3yrs

Recent management updates

Recent updates

CEO

Cliff Wang

8.2yrs

Tenure

Dr. Cliff C. Wang, Ph D., has been Chief Executive Officer of Original BioMedicals Co., Ltd. since October 1, 2016 and serves as its Director.Dr. Wang served as Vice President and Director of Original Bio...

Leadership Team

NamePositionTenureCompensationOwnership
Duncan Chen
Chairman & CTOno datano datano data
Cliff Wang
Chief Executive Officer and Director8.2yrsno datano data
Selena Lin
Chief Financial Officer8.2yrsno datano data
Hsiao-Pao Yen
Chief Operating Officer and Director8.2yrsno datano data
Cecilia Hung
Director of Developmentno datano datano data
Alan Liss
Senior Vice President8.3yrsno datano data
Gan Ping
Head of Clinical Research Departmentno datano datano data

8.2yrs

Average Tenure

Experienced Management: 6483's management team is seasoned and experienced (8.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Duncan Chen
Chairman & CTOno datano datano data
Cliff Wang
Chief Executive Officer and Directorno datano datano data
Hsiao-Pao Yen
Chief Operating Officer and Director8.3yrsno datano data
Ping-Ho Yan
Independent Directorno datano datano data
Ging-Ho Hsiue
Member of Scientific Advisory Boardno datano datano data
Min-Liang Kuo
Member of Scientific Advisory Boardno datano datano data
Johnson Lin
Member of Scientific Advisory Boardno datano datano data
Huang Shi
Independent Directorno datano datano data
Sue-Fung Wang
Independent Director8.3yrsno datano data
Chih-Chen Hsu
Independent Director8.3yrsno datano data
Roy Hsiao
Director7.5yrsno datano data

8.3yrs

Average Tenure

Experienced Board: 6483's board of directors are considered experienced (8.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 23:10
End of Day Share Price 2024/12/26 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Original BioMedicals Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution